Prot# MFG4809g: An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date7/27/107/27/13

Funding

  • Genentech, Inc. (MFG4809g)